Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.5M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
9.65M
-
Shares change
-
+9.64M
-
Total reported value, excl. options
-
$137M
-
Value change
-
+$137M
-
Put/Call ratio
-
0.69
-
Number of buys
-
83
-
Price
-
$14.17
Significant Holders of Inhibrx Biosciences, Inc. - Common Stock (INBX) as of Q2 2024
93 filings reported holding INBX - Inhibrx Biosciences, Inc. - Common Stock as of Q2 2024.
Inhibrx Biosciences, Inc. - Common Stock (INBX) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.65M shares
of 14.5M outstanding shares and own 66.67% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (1.79M shares), PERCEPTIVE ADVISORS LLC (1.06M shares), BlackRock Inc. (683K shares), VANGUARD GROUP INC (478K shares), Walleye Capital LLC (475K shares), Sofinnova Investments, Inc. (463K shares), Slotnik Capital, LLC (342K shares), ALPINE ASSOCIATES MANAGEMENT INC. (306K shares), MILLENNIUM MANAGEMENT LLC (303K shares), and TIG Advisors, LLC (244K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.